PeerVoice Endocrinology & Metabolic Disorders Audio
PeerVoice
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Categorieën: Wetenschap en geneeskunde
Toevoegen aan Mijn lijst
Luister naar de laatste aflevering:
Visit https://www.peervoice.com/QKR860 to view the entire programme with slides. After completing “Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 Diabetes”, participants will be able to: Use recommended screening tests to identify chronic kidney disease (CKD) in patients with type 2 diabetes mellitus (T2DM); Evaluate current efficacy and safety evidence guiding the use of novel treatments for CKD in T2DM; and Apply best practices for the initiation and management of novel therapies for treatment of CKD and T2DM.
Vorige afleveringen
-
109 - Fatos Pinar Topsever, MD / Jennifer Green, MD - CGA - Identify and Intervene: Optimising Care Pathways for Chronic Kidney Disease in Patients With Type 2 DiabetesThu, 28 Mar 2024
-
108 - George Kassianos, CBE, MD (Hons), FRCGP / Gili Regev-Yochay, MD - Current 2024 COVID-19 Vaccination Campaign: The Evidence Supporting the Call to ActionWed, 28 Feb 2024
-
107 - Carel le Roux, MD, PhD - Prioritising Obesity Care in Our Clinical Practices: Why We Must and How We CanMon, 22 Jan 2024
-
106 - Meena B. Bansal, MD, FAASLD - The Many Faces of MASH: Recognising Risk, Improving Identification, and Maximising Management in the Primary Care SettingWed, 3 Jan 2024
-
105 - Andreea Ciudin, MD, PhD - Adjusting Our Mindset and Our Approach: Patient and Provider Perspectives on the Modernisation of Obesity CareThu, 21 Dec 2023
-
104 - Lise Lotte Gluud, MD - Following the Evidence-Based Road: Improving Care for MASH Through Use of Clinical Care Pathways in Primary CareTue, 28 Nov 2023
-
103 - Tina Vilsbøll, MD, DMSc - Overcoming Barriers to Basal Insulin in T2DM: Appreciating the Preferences and Perspectives of Patients With T2DMMon, 30 Oct 2023
-
102 - Paolo Sbraccia, MD, PhD - Providing State of the Art Care for People With Obesity: Can We Break Free From the Status Quo?Mon, 30 Oct 2023
-
101 - Harpreet Bajaj, MD, MPH - Innovating Our Approach to the Initiation of Insulin in T2DM: The Why and the HowFri, 29 Sep 2023
-
100 - Melanie J. Davies, CBE, FRCP, FMedSci / Linong Ji, MD - Managing the Cost of Type 2 Diabetes: The Impact of Effective Use of Established TherapiesWed, 23 Aug 2023
-
99 - Mansoor Husain, MD - Integrating GLP-1 RAs Into Our Cardiology Care Pathways: Who, When, and Why?Tue, 22 Aug 2023
-
98 - Sarah Jarvis, MBE, FRCGP - Achieving Shared Goals Across the Spectrum of CKD and HFTue, 22 Aug 2023
-
97 - Janaka Karalliedde, FRCP, PhD - Stroke Prevention in T2DM: The Neuroprotective Benefits of GLP-1 RAsMon, 5 Dec 2022
-
96 - Melanie J. Davies, CBE, FRCP, FMedSci - Proactive Stroke Risk Mitigation Strategies: Taking Aim in Type 2 DiabetesMon, 5 Dec 2022
-
95 - Kieran McCafferty, MB BChir, MRCP, MD (res) / Shelley Zieroth, MD, FRCPC, FHFSA (hon) - Handling Hyperkalaemia Without Compromising Care for Chronic Kidney Disease and Heart FailureWed, 26 Jul 2023
-
94 - Sarah Jarvis, MBE, FRCGP - Identifying Intervention Points in CKD and HF From Multidisciplinary ViewpointsMon, 19 Jun 2023
-
93 - Verónica Vázquez Velázquez, PhD - Optimising Obesity Care in Adolescent Patients: Practical Blueprints to Overcome BarriersFri, 12 May 2023
-
92 - George L. Bakris, MD, MA - Step-by-Step: Setting a Course for Managing CKD and T2DM With Nonsteroidal MRAsFri, 5 May 2023
-
91 - Luis Alberto Moreno, MD, PhD / Aaron Kelly, PhD - Assessing and Alleviating the Weight of Obesity in Adolescent PatientsWed, 19 Apr 2023
-
90 - Kevin Fernando, FRCGP, FRCP Edin., FAcadMEd - Simplified Strategies to Optimise Obesity Management for Primary Point of Contact CliniciansTue, 11 Apr 2023
-
89 - Angela Fitch, MD, FACP, Dipl. ABOM - Give the Heart a Break: Improving Cardiovascular Risk and Outcomes With Modern Weight Management StrategiesThu, 30 Mar 2023
-
88 - Kausik Ray, MD, MPhil (Cantab), MBChB - Taking Obesity to Heart: The Role of the Cardiologist in Incorporating Obesity Care Into Cardiovascular Care to Enhance Patient OutcomesThu, 23 Mar 2023
-
87 - Samuel Seidu, MD, FRCGP, FRCP (Edin) - The Power of the Primary Point of Contact: Taking Obesity From Obstacle to OpportunityThu, 23 Mar 2023
-
86 - Jens Lundgren, MD - Applying Current European Guidance on Treating COVID-19 in Hospitalized PatientsThu, 23 Mar 2023
-
85 - Sharon Cohen, MD, FRCPC - Inflammation and the Brain: Why We Need To Know MoreFri, 3 Feb 2023
-
84 - Mauro Bernardi, MD - The Functional Quality of Albumin in Fluid Management of Patients with Liver Cirrhosis: Just a Concept or Does it Matter?Fri, 3 Feb 2023
-
83 - Tali Cukierman-Yaffe, MD, MSc - Beyond Metabolic Benefits: Recognising and Reducing the Risk of Stroke in Type 2 Diabetes With GLP-1 RAsFri, 16 Dec 2022
-
82 - Melanie J. Davies, CBE, FRCP, FMedSci - Clinical Challenges in Insulin Initiation: Overcoming Obstacles to Improved Glycaemic Control in Type 2 DiabetesMon, 5 Dec 2022
-
80 - Aoife Egan, MB, BCh, PhD - Insulin Resistance and Women’s Health: Case Studies in Gestational Diabetes and Polycystic Ovarian SyndromeFri, 11 Nov 2022
-
79 - "Pantelis Sarafidis, MD, MSc, PhD - Meeting the Challenge of Improving Outcomes in CKD and T2DM: A Call to Action for Clinicians "Mon, 7 Nov 2022
-
78 - Metabolic Health of PLWH: What Needs to Be Considered When Initiating or Switching ART?Tue, 20 Sep 2022
-
77 - Managing Long-Chain Fatty Acid Disorders: Experience of Novel Therapies in the Real WorldTue, 24 May 2022
Meer afleveringen weergeven
5
